CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (10,851,000)	$ (157,533,000)	$ (62,458,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	111,206,000	115,235,000	111,860,000
Impairment charges on real estate	6,847,000	45,459,000	0
Equity in income of unconsolidated entity	11,202,000	35,614,000	92,812,000
Deferred rents	(8,553,000)	(7,635,000)	(10,896,000)
Amortization of above- and below-market leases, net	(456,000)	(769,000)	(1,280,000)
Amortization of deferred financing costs	9,524,000	4,243,000	3,940,000
Unrealized losses (gains) on derivative instruments	6,833,000	16,451,000	(52,189,000)
Gain related to swap terminations	(178,000)	0	0
Interest rate swap settlement for early terminated swaps	6,552,000	0	0
Gain from extinguishment of debt	(56,372,000)	0	0
Gain on sale of real estate	(53,064,000)	0	0
Write-off of prepaid offering costs	0	0	2,728,000
Interest rate swap settlements for off-market swap instruments	0	(9,138,000)	(1,543,000)
Changes in operating assets and liabilities:
Rents and other receivables	(7,317,000)	(3,149,000)	3,044,000
Due from affiliates	0	10,000	333,000
Prepaid expenses and other assets	(12,833,000)	(14,441,000)	(16,395,000)
Accounts payable and accrued liabilities	3,337,000	(1,323,000)	(2,598,000)
Due to affiliates	1,612,000	7,043,000	2,239,000
Other liabilities	164,000	11,567,000	6,368,000
Net cash provided by operating activities	7,653,000	41,634,000	75,965,000
Cash Flows from Investing Activities:
Improvements to real estate	(34,469,000)	(81,219,000)	(121,568,000)
Proceeds from sale of real estate, net	192,371,000	0	0
Purchase of interest rate cap	0	(25,000)	0
Net cash provided by (used in) investing activities	157,902,000	(81,244,000)	(121,568,000)
Cash Flows from Financing Activities:
Proceeds from notes payable	35,913,000	77,170,000	282,118,000
Principal payments on notes payable	(198,463,000)	(9,952,000)	(83,013,000)
Payments of deferred financing costs	(10,465,000)	(2,887,000)	(1,155,000)
Interest rate swap settlements for off-market swap instruments	0	9,853,000	569,000
Restricted cash surrendered from deed-in-lieu of foreclosure	(1,886,000)	0	0
Payments to redeem common stock	0	(12,142,000)	(89,183,000)
Payments of prepaid other offering costs	0	0	(110,000)
Payments of other offering costs	(2,000)	(28,000)	(17,000)
Distributions paid to common stockholders	0	(25,319,000)	(56,205,000)
Net cash (used in) provided by financing activities	(174,903,000)	36,695,000	53,004,000
Net (decrease) increase in cash, cash equivalents and restricted cash	(9,348,000)	(2,915,000)	7,401,000
Cash, cash equivalents and restricted cash, beginning of period	50,922,000	53,837,000	46,436,000
Cash, cash equivalents and restricted cash, end of period	41,574,000	50,922,000	53,837,000
Supplemental Disclosure of Cash Flow Information:
Interest paid	92,521,000	93,657,000	55,245,000
Supplemental Disclosure of Noncash Investing and Financing Activities:
Distributions payable	0	0	7,374,000
Mortgage loan extinguished in connection with deed-in-lieu of foreclosure	125,000,000	0	0
Real estate transferred in connection with deed-in-lieu of foreclosure	69,028,000	0	0
Net liabilities transferred in connection with deed-in-lieu of foreclosure	2,286,000	0	0
Distributions paid to common stockholders through common stock issuances pursuant to the dividend reinvestment plan	0	16,249,000	33,391,000
Redeemable common stock payable	0	0	711,000
Accrued improvements to real estate	6,885,000	14,222,000	19,324,000
Accrued deferred loan financing costs	5,347,000	0	0
Accrued disposition fees	500,000	0	0
Accrued interest rate swap settlements related to off-market swap instruments	$ 0	$ 0	$ (974,000)